Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion type Assertion NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_head.
- NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion description "[2-phenylimidazo[2,1-b]benzothiazole derivatives have been highlighted for their properties of targeting oncogenic Met receptor tyrosine kinase (RTK) signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_provenance.
- NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion evidence source_evidence_literature NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_provenance.
- NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion SIO_000772 23071625 NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_provenance.
- NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion wasDerivedFrom befree-20150227 NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_provenance.
- NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_assertion wasGeneratedBy ECO_0000203 NP803137.RA3HyIeiZRtk84eaxmtrrZ9Zg-oC8fFz5bELC-vSXezy4130_provenance.